HOMOGENOUS PHARMACEUTICAL ORAL DOSAGE FORMS COMPRISING LERCANIDIPINE AND ENALAPRIL OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS WITH AN ORGANIC ACID

摘要

The invention relates to combined pharmaceutical solid oral dosage forms comprising lercanidipine or a pharmaceutically acceptable salt thereof as the active substance, enalapril or a pharmaceutically acceptable salt thereof as the active substance, and an organic acid selected from citric acid and/or maleic acid.